Venmax Drugs & Pharmaceuticals Ltd

As of 03-Nov, Venmax Drugs & Pharmaceuticals Ltd is experiencing a price increase to 28.70, with a recent gain of 10.09% over three days and a 42.43% rise in the past month, outperforming the Sensex. However, a significant decline in delivery volume by 77.96% raises concerns about sustained investor interest.

As of 28-Oct, Venmax Drugs & Pharmaceuticals Ltd is priced at 27.88, down 1.31%. Despite recent declines, the stock has shown strong monthly and year-to-date performance, but its short-term drop contrasts with overall positive trends and outperformance against the Sensex.

As of 24-Oct, Venmax Drugs & Pharmaceuticals Ltd is experiencing a price increase to Rs 29.71, up 4.61%, with strong performance over the past nine days and significant outperformance compared to the Sensex. The stock is trending bullish, supported by increased delivery volume and a notable rise in returns both short-term and year-to-date.

As of 17-Oct, Venmax Drugs & Pharmaceuticals Ltd is seeing a price increase to Rs 25.44, up 4.99%, with strong weekly and monthly gains. Despite a significant drop in investor participation, the stock has outperformed the Sensex, indicating positive sentiment.

As of 15-Oct, Venmax Drugs & Pharmaceuticals Ltd is experiencing a price increase to Rs 23.08, up 4.96%, with strong short-term performance but an 11.40% decline over the past month and decreased investor participation. The stock has outperformed the Sensex significantly year-to-date, indicating resilience despite mixed long-term signals.

As of 13-Oct, Venmax Drugs & Pharmaceuticals Ltd is currently priced at 20.95, reflecting a 4.96% increase and significant investor interest with a 119.92% rise in delivery volume. Despite recent volatility, the stock has outperformed the Sensex year-to-date, indicating a recovery phase and improved trading activity.

As of 06-Oct, Venmax Drugs & Pharmaceuticals Ltd is facing a stock price decline to 19.22, down 4.62%, and has underperformed significantly against the Sensex, with a 22.19% drop in the last month. The stock is trading below all key moving averages and has seen a substantial decrease in delivery volume, indicating a bearish trend and reduced investor interest.

As of 26-Sep, Venmax Drugs & Pharmaceuticals Ltd's stock price is Rs 22.10, down 4.91%, and has declined 7.57% over the last two days. The stock has significantly underperformed its sector and the broader market, with steep declines over the past week and month, indicating a challenging period for the company.

As of 24-Sep, Venmax Drugs & Pharmaceuticals Ltd is priced at 23.91, showing a slight increase but trading below all key moving averages, indicating a bearish trend. The stock has outperformed its sector today, but has underperformed the benchmark Sensex in the short term, with a significant decline over the past month.

As of 23-Sep, Venmax Drugs & Pharmaceuticals Ltd's stock price is Rs 23.85, down 4.98%, and has declined 9.66% over the last two days. The stock is underperforming its sector and the Sensex, with significantly reduced investor participation, indicating a bearish trend.

As of 22-Sep, Venmax Drugs & Pharmaceuticals Ltd's stock price is Rs 25.10, down 4.92%, and has underperformed its sector. Despite a year-to-date gain of 39.14%, recent trends indicate a decline in value and investor sentiment.

As of 19-Sep, Venmax Drugs & Pharmaceuticals Ltd is currently priced at Rs 26.40, reflecting a recent increase but has underperformed over the past week and month. Despite a year-to-date gain of 46.34%, declining investor participation raises concerns about the stock's sustained interest.

As of 18-Sep, Venmax Drugs & Pharmaceuticals Ltd is currently priced at Rs 25.25, reflecting a 4.99% increase today after three days of decline. Despite this short-term rebound, the stock has underperformed over the past week and month, with significant drops in investor participation.

As of 17-Sep, Venmax Drugs & Pharmaceuticals Ltd is priced at 24.05, having declined 2.91% over the last three days, totaling a drop of 12.1%. The stock is trading below all major moving averages and has significantly underperformed compared to the Sensex, which has risen while Venmax has seen a 15.64% decline over the past month.

As of 16-September, Venmax Drugs & Pharmaceuticals Ltd's stock price is Rs 24.77, down 4.91%, and has underperformed its sector by 5.19% today. Despite a strong year-to-date return of 37.31%, recent trends indicate a decline in both short-term performance and investor participation.

As of 15-Sep, Venmax Drugs & Pharmaceuticals Ltd's stock price is Rs 26.05, down 4.79%, underperforming its sector and showing decreased investor participation. Despite a strong year-to-date return of 44.40%, recent volatility and a decline over the past month highlight specific challenges for the company.

As of 10-Sep, Venmax Drugs & Pharmaceuticals Ltd's stock price is Rs 24.00, down 4.76%, with a significant decline of 12.28% over the past week and 17.72% over the past month, despite a year-to-date increase of 33.04%. The stock is experiencing mixed signals, trading above its 200-day moving average but below shorter-term averages, while investor participation has notably increased despite the price drop.

As of 09-Sep, Venmax Drugs & Pharmaceuticals Ltd is currently priced at Rs 25.20, showing a 5.0% increase today after eight days of decline, but it has experienced significant volatility and a 12.47% drop over the past week. Despite a strong year-to-date return of 39.69%, decreased investor participation and recent declines indicate challenges diverging from broader market trends.

As of 08-Sep, Venmax Drugs & Pharmaceuticals Ltd is facing a significant decline in its stock price, down 30.64% over the last eight days, with a current price of 24.00. Despite a positive year-to-date return of 33.04%, recent performance and decreased investor participation indicate negative market sentiment.